Venture Map · Round
ViveBiotech — Series A · €1.1M
Announced 2022-12-15 · San Sebastián · Biotech / Viral vectors
ViveBiotech develops and manufactures lentiviral vectors for gene therapy. It closed a new €1.1M round.
RoundSeries A
Amount€1.1M
LeadNot disclosed
Date2022-12-15
CitySan Sebastián
SectorBiotech / Viral vectors
